~~<i id='CCE53CDE95'><strike id='CCE53CDE95'><tt id='CCE53CDE95'><pre id='CCE53CDE95'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

author：focus 2025-09-27 12:48:04 - browse：65198

David Liu- Broad Retreat — David Liu proposed prime editing of genes in 2019. The technology has passed a big test. Courtesy ErikJacobs/Broad Institute

Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys.

The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases.

“I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said Jeremy Duffield, Prime’s chief scientific officer.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical records are filled with copy
Next article： Elisabeth Bik tackles the widespread issue of research misconduct

focus

hotspot

focus

Adoctorflushesadonorkidneyduringatransplantprocedure.BRENDANSMIALOWSKI/AFP/GettyImagesAsIwasgettingr

WSS

Medicare isn't yet testing food as medicine

Cholera vaccine supplies dangerously low, outbreaks surging

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

International team creates first chimeric human

Color Health wants to make cancer screenings convenient

entertainment

entertainment

focus

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

ALS groups 'won't be played again' by the FDA, drug sponsors

Duchenne breakthrough therapy leaves behind pioneering families

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

Duchenne breakthrough therapy leaves behind pioneering families

ALS groups 'won't be played again' by the FDA, drug sponsors

Peter Hotez and the public health issue of online harassment

FDA does about

Continuity nursing helped my family in our darkest PICU moments

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

focus

STAT Madness 2024: Meet the contenders

Study fuels hope CAR

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

ALS groups 'won't be played again' by the FDA, drug sponsors

Redefining sustainability for the pharmaceutical industry

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

hotspot

hotspot

hotspot

focus